UPDATE 1-U.S. appeals court upholds ruling that canceled Teva Copaxone patents
October 12, 2018 at 10:32 AM EDT
A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone.
